03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lipostat 40mg** : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Manufacturer | Pharmaline SAL* |
Manufacturing Type | Pharmaline Licensed by Glaxo SmithKline Export Ltd , UK |
Origin | Lebanon |
ATC | C10AA03 |
Lipostat 40mg** :
Lipostat 40mg** :
Lipostat 40mg** :
Lipostat 40mg** :
Lipostat 40mg** :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Lipostat 40mg** :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Alopecia | Uncommon |
Anaphylaxis | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Arthralgia (Pain joint) (Joint ache) | Not known |
Blood creatine phosphokinase increased | Not known |
Constipation | Uncommon |
Cutaneous lupus erythematosus-like reactions | Very rare |
Diarrhoea (Diarrhea) | Uncommon |
Diplopia | Uncommon |
Dizziness | Uncommon |
Dyspepsia | Uncommon |
Dysuria (Micturition painful) | Uncommon |
Fatigue | Uncommon |
Flatulence | Uncommon |
Hair disorder | Uncommon |
Headache | Uncommon |
Hepatic necrosis | Very rare |
Hepatitis | Very rare |
Hypersensitivity reactions | Very rare |
Insomnia | Uncommon |
Jaundice | Very rare |
Muscle cramps | Not known |
Muscle weakness | Not known |
Musculoskeletal pain | Not known |
Myalgia | Not known |
Myoglobinuria | Very rare |
Myopathy | Very rare |
Myositis | Very rare |
Nausea | Uncommon |
Nocturia | Uncommon |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Very rare |
Pollakiuria (Urinary frequency) | Uncommon |
Polymyositis | Very rare |
Polyneuropathy | Very rare |
Pruritus | Uncommon |
Pyrosis (Heartburn) | Uncommon |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
Rhabdomyolysis | Very rare |
Scalp disorder | Uncommon |
Sexual dysfunction | Uncommon |
Skin rash | Uncommon |
Sleep disorder (Sleep disturbance) | Uncommon |
Tendon disorder | Very rare |
Tendon rupture | Very rare |
Transaminases increased | Not known |
Urination impaired | Uncommon |
Urticaria | Uncommon |
Vision blurred | Uncommon |
Visual disturbance | Uncommon |
Vomiting | Uncommon |
Lipostat 40mg** :
NB : Products With Same Indication |
Different Units By MoH Code
Lipostat 40mg** MoH 6742 :
Form | Tablet |
Packaging | Blisters |
Package Size | Box of 30 |
Strength | 40mg |
Storage Condition | <25°C protect from humidity & light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 97529/11 |
Submission date | 01/01/2011 |
Registration Year | 2012 |
Archived Date | 02/07/2020 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 30 | |
● Public Price: | 191 QAR | ( 4,690,578.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 6,3667 QAR | ( 147,348.00 LBP ) |
● Pharmacy Price: | 156.365966302 QAR | ( 3840035.4004445 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 188 AED | ( 4,542,268.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 6,2667 AED | ( 144,966.00 LBP ) |
● Pharmacy Price: | 151.51 AED | ( 3660633.11 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 30's HDPE Bottle | |
● Public Price: | 188 AED | ( 4,542,268.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 6,2667 AED | ( 144,966.00 LBP ) |
● Pharmacy Price: | 151.51 AED | ( 3660633.11 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 6.16 EUR | ( 596,756.16 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,22 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 6 EUR | |
● Pricing Date: | 01/08/2019 | |
● Type: | Medicine Non Marketed |
● Country: | UK | |
● Package Size: | 28 | |
● Public Price: | 26.01 GBP | ( 2,956,010.49 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,9289 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Bahrain | |
● Package Size: | 30 | |
● Public Price: | 18.27 BHD | ( 4,343,400.18 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,609 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 04/01/2019 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 30 | |
● Public Price: | 8.59 EUR | ( 832,164.84 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2863 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 5.94 EUR | |
● Pharmacy Price: | 6.23 EUR | ( 603537.48 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File